Sirtuin1 Expression and Correlation with Histopathological Features in Retinoblastoma

Area of Science:

• Oncology
• Molecular Biology
• Ophthalmology

Background:

• Sirtuin1 (Sirt1) plays a dual role in cancer, acting as both a tumor promoter and suppressor.
• Sirt1 can inhibit tumor suppressor functions by deacetylating proteins like the retinoblastoma protein.
• The expression of Sirt1 in retinoblastoma has not been previously studied.

Purpose of the Study:

• To investigate the expression of Sirtuin1 (Sirt1) in retinoblastoma tissues.
• To correlate Sirt1 expression with histopathological features and patient survival.

Main Methods:

• Immunohistochemistry was used to assess Sirt1 expression in 94 archived retinoblastoma tissue samples.
• Histopathological features were reviewed and correlated with Sirt1 expression levels.
• The impact of Sirt1 expression on overall and progression-free survival was analyzed.

Main Results:

• Sirt1 was expressed in 95% of the retinoblastoma specimens analyzed.
• 48% of specimens showed high-grade Sirt1 staining (>75% of cells), with 53% exhibiting 3+ intensity.
• No significant association was found between Sirt1 expression levels and histopathological features or patient survival.

Conclusions:

• Sirtuin1 (Sirt1) is widely expressed in retinoblastoma.
• The level of Sirt1 expression in retinoblastoma is not linked to aggressive histopathological characteristics or patient prognosis.